Literature DB >> 23364150

Examining the relationship between alopecia areata, androgenetic alopecia, and emotional intelligence.

Assaf Monselise1, Reuven Bar-On, Lisa Chan, Naama Leibushor, Kevin McElwee, Jerry Shapiro.   

Abstract

BACKGROUND: Emotional stress has been associated with the development of alopecia areata (AA) and androgenetic alopecia (AGA). Emotional intelligence (EI), a component of general intelligence, is thought to govern the recognition, expression, and control of stress and other emotions. People with low EI are unable to adequately control stress in everyday life.
OBJECTIVE: To investigate EI differences between AA and AGA patients and a control population.
METHODS: Thirty-five AGA patients and 42 AA patients, with patchy (n  =  28), ophiasis (n  =  5), totalis (n  =  5), and universalis (n  =  4) distribution of hair loss, completed a 133-item Emotional Quotient-Inventory (EQ-I ) psychometric assessment. Scores were compared between AA, AGA, and 77 control subjects obtained from the North American normative population sample on which the psychometric instrument was normed.
RESULTS: Statistically significant differences were found in EI between AA patients and controls with the EQ-I Stress Tolerance scale (p  =  .005). AGA patients also differed significantly from the controls but to a lesser degree compared toAA patients. In overall EI, there were no apparent differences between AGA and AA patients.
CONCLUSIONS: AA and AGA patients exhibit a mild depressive reaction to their condition, with AA patients demonstrating a significantly stronger deficiency in coping with stress than AGA patients. The data support a psychosomatic contribution to AA. Referral of patients for EI assessment and psychosocial counseling could help reduce stress.

Entities:  

Mesh:

Year:  2013        PMID: 23364150     DOI: 10.2310/7750.2012.12003

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  8 in total

1.  Androgenetic Alopecia Treatment in Asian Men.

Authors:  Yohei Tanaka; Toru Aso; Jumpei Ono; Ryu Hosoi; Takuto Kaneko
Journal:  J Clin Aesthet Dermatol       Date:  2018-07-01

Review 2.  Mouse Models of Alopecia Areata: C3H/HeJ Mice Versus the Humanized AA Mouse Model.

Authors:  Amos Gilhar; Rimma Laufer Britva; Aviad Keren; Ralf Paus
Journal:  J Investig Dermatol Symp Proc       Date:  2020-11

3.  Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review.

Authors:  Arash Mostaghimi; Lynne Napatalung; Vanja Sikirica; Randall Winnette; Jason Xenakis; Samuel H Zwillich; Boris Gorsh
Journal:  Dermatol Ther (Heidelb)       Date:  2021-03-26

4.  Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review.

Authors:  Atrin Toussi; Virginia R Barton; Stephanie T Le; Oma N Agbai; Maija Kiuru
Journal:  J Am Acad Dermatol       Date:  2020-06-17       Impact factor: 15.487

Review 5.  Hair camouflage: A comprehensive review.

Authors:  Stephanie Saed; Omer Ibrahim; Wilma F Bergfeld
Journal:  Int J Womens Dermatol       Date:  2016-10-31

Review 6.  Hair camouflage: A comprehensive review.

Authors:  Stephanie Saed; Omer Ibrahim; Wilma F Bergfeld
Journal:  Int J Womens Dermatol       Date:  2017-02-16

7.  An anti-hair loss treatment in the management of mild androgenetic alopecia: Results from a large, international observational study.

Authors:  Pascal Reygagne; Victor Desmond Mandel; Catherine Delva; Michaela Havlíčková; Kamila Padlewska; Rose Khalil; Veronique Meuleman; Gilberto Adame Miranda; Mariya Nevskaya; Jean-Francois Michelet; Florence Pouradier; Sergio Vano-Galvan; Delphine Kerob
Journal:  Dermatol Ther       Date:  2021-10-22       Impact factor: 3.858

Review 8.  Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.

Authors:  Talagavadi Channaiah Anudeep; Madhan Jeyaraman; Sathish Muthu; Ramya Lakshmi Rajendran; Prakash Gangadaran; Prabhu Chandra Mishra; Shilpa Sharma; Saurabh Kumar Jha; Byeong-Cheol Ahn
Journal:  Pharmaceutics       Date:  2022-03-10       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.